{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T11:08:46Z","timestamp":1769684926548,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ygyno.2008.11.015","type":"journal-article","created":{"date-parts":[[2008,12,26]],"date-time":"2008-12-26T04:17:26Z","timestamp":1230265046000},"page":"637-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Vitamin A metabolism is impaired in human ovarian cancer"],"prefix":"10.1016","volume":"112","author":[{"given":"Stephen J.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusica","family":"Cvetkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2008.11.015_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-4652(200010)185:1<1::AID-JCP1>3.0.CO;2-O","article-title":"Retinoids and ovarian cancer","volume":"185","author":"Zhang","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ygyno.2008.11.015_bib2","series-title":"Retinoids in oncology","author":"Degos","year":"1995"},{"issue":"9","key":"10.1016\/j.ygyno.2008.11.015_bib3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fasebj.10.9.8801164","article-title":"Retinoids in cancer chemoprevention","volume":"10","author":"Lotan","year":"1996","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.ygyno.2008.11.015_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.leu.2402414","article-title":"Classical and novel retinoids: their targets in cancer therapy","volume":"16","author":"Fontana","year":"2002","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.ygyno.2008.11.015_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-4652(200011)185:2<302::AID-JCP15>3.0.CO;2-#","article-title":"Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells","volume":"185","author":"Mira","year":"2000","journal-title":"J. Cell. Physiol."},{"issue":"18","key":"10.1016\/j.ygyno.2008.11.015_bib6","doi-asserted-by":"crossref","first-page":"8118","DOI":"10.1158\/0008-5472.CAN-04-4562","article-title":"The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer","volume":"65","author":"Kim","year":"2005","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.ygyno.2008.11.015_bib7","first-page":"2186","article-title":"Abnormal level of retinoic acid in prostate cancer tissues","volume":"81","author":"Pasquali","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.ygyno.2008.11.015_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1753-4887.2000.tb01870.x","article-title":"A gene knockout corroborates the integral function of cellular retinol-binding protein in retinoid metabolism","volume":"58","author":"Napoli","year":"2000","journal-title":"Nutr. Rev."},{"issue":"1","key":"10.1016\/j.ygyno.2008.11.015_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jnci\/dji031","article-title":"A crucial role for cellular retinol-binding protein I in retinoid signaling","volume":"97","author":"Lotan","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"2\u20133","key":"10.1016\/j.ygyno.2008.11.015_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1388-1981(99)00117-1","article-title":"Interactions of retinoid binding proteins and enzymes in retinoid metabolism","volume":"1440","author":"Napoli","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.ygyno.2008.11.015_bib11","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1096\/fasebj.10.9.8801168","article-title":"Defective expression of cellular retinol binding protein type I and retinoic acid receptors alpha2, beta2, and gamma2 in human breast cancer cells.","volume":"10","author":"Jing","year":"1996","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.ygyno.2008.11.015_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/92.6.475","article-title":"Cellular retinol-binding protein expression and breast cancer","volume":"92","author":"Kuppumbatti","year":"2000","journal-title":"J Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2008.11.015_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1593\/neo.04370","article-title":"Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma","volume":"7","author":"Kwong","year":"2005","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.ygyno.2008.11.015_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1535-6108(02)00215-5","article-title":"Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma","volume":"2","author":"Yamashita","year":"2002","journal-title":"Cancer Cell."},{"issue":"5","key":"10.1016\/j.ygyno.2008.11.015_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ijc.20936","article-title":"CpG island methylation in aberrant crypt foci and cancers from the same patients","volume":"115","author":"Luo","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2008.11.015_bib16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/jhep.2003.50321","article-title":"Cellular retinol-binding protein-1 in hepatocellular carcinoma correlates with beta-catenin, Ki-67 index, and patient survival","volume":"38","author":"Schmitt-Graff","year":"2003","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.ygyno.2008.11.015_bib17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jcp.2003.014555","article-title":"Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer","volume":"57","author":"Jeronimo","year":"2004","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2008.11.015_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2144\/99262st02","article-title":"Optimization of single-cell gel electrophoresis (SCGE) for quantitative analysis of neuronal DNA damage","volume":"26","author":"Morris","year":"1999","journal-title":"Biotechniques"},{"issue":"4","key":"10.1016\/j.ygyno.2008.11.015_bib19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/10428190290016999","article-title":"The expression of cellular retinoid binding proteins in non-APL leukemic cells and its association with retinoid sensitivity","volume":"43","author":"Lehmann","year":"2002","journal-title":"Leuk. Lymphoma"},{"issue":"21","key":"10.1016\/j.ygyno.2008.11.015_bib20","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1158\/0008-5472.CAN-06-1052","article-title":"A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: implications for predicting breast cancer risk","volume":"66","author":"Bistulfi","year":"2006","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ygyno.2008.11.015_bib21","first-page":"2774","article-title":"Reduced levels of retinyl esters and vitamin A in human renal cancers","volume":"61","author":"Guo","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2008.11.015_bib22","first-page":"83","article-title":"A population-based case-control study of carotenoid and vitamin A intake and ovarian cancer (United States)","volume":"12","author":"Bertone","year":"2001","journal-title":"Cancer Causes Control"},{"issue":"9","key":"10.1016\/j.ygyno.2008.11.015_bib23","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/1097-0142(20011101)92:9<2318::AID-CNCR1578>3.0.CO;2-7","article-title":"Risk of ovarian carcinoma and consumption of vitamins A, C, and E and specific carotenoids: a prospective analysis","volume":"92","author":"Fairfield","year":"2001","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2008.11.015_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ijc.1435","article-title":"Carotenoids, antioxidants and ovarian cancer risk in pre- and postmenopausal women","volume":"94","author":"Cramer","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2008.11.015_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0885-4505(87)90029-6","article-title":"The relationship of serum vitamin A, cholesterol, and triglycerides to the incidence of ovarian cancer","volume":"37","author":"Das","year":"1987","journal-title":"Biochem. Med. Metab. Biol."},{"issue":"3","key":"10.1016\/j.ygyno.2008.11.015_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00931311","article-title":"Serum vitamins A and E and carotene in patients with gynecologic cancer","volume":"241","author":"Heinonen","year":"1987","journal-title":"Arch. Gynecol. Obstet."},{"issue":"21","key":"10.1016\/j.ygyno.2008.11.015_bib27","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/jnci\/91.21.1847","article-title":"Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer","volume":"91","author":"Veronesi","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2008.11.015_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jnci\/87.2.146","article-title":"Can fenretinide protect women against ovarian cancer?","volume":"87","author":"De Palo","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.ygyno.2008.11.015_bib29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jnci\/84.8.592","article-title":"Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer","volume":"84","author":"Godwin","year":"1992","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.ygyno.2008.11.015_bib30","first-page":"2778","article-title":"Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity","volume":"54","author":"Testa","year":"1994","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2008.11.015_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/10445490252810276","article-title":"Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium","volume":"21","author":"Roberts","year":"2002","journal-title":"DNA Cell Biol."},{"issue":"3","key":"10.1016\/j.ygyno.2008.11.015_bib32","first-page":"1013","article-title":"Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer","volume":"9","author":"Cvetkovic","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2008.11.015_bib33","first-page":"57","article-title":"Immunohistochemistry for CRBPs and CRABPs","volume":"89","author":"Eriksson","year":"1998","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ygyno.2008.11.015_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0076-6879(90)89303-Y","article-title":"Tissue distribution of cellular retinol-binding protein and cellular retinoic acid-binding protein: use of monospecific antibodies for immunohistochemistry and cRNA for in situ localization of mRNA","volume":"189","author":"Busch","year":"1990","journal-title":"Methods Enzymol."},{"issue":"2","key":"10.1016\/j.ygyno.2008.11.015_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/gyno.1999.5348","article-title":"Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer","volume":"73","author":"Kruk","year":"1999","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2008.11.015_bib36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0002-9378(95)90282-1","article-title":"Expression of two mucin antigens in cultured human ovarian surface epithelium: influence of a family history of ovarian cancer","volume":"173","author":"Auersperg","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2008.11.015_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0002-9378(11)91579-8","article-title":"Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix","volume":"167","author":"Maines-Bandiera","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.ygyno.2008.11.015_bib38","first-page":"5379","article-title":"Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors","volume":"43","author":"Hamilton","year":"1983","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.ygyno.2008.11.015_bib39","first-page":"5895","article-title":"Genetic analysis of early- versus late-stage ovarian tumors","volume":"61","author":"Shridhar","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2008.11.015_bib40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1054\/bjoc.2001.1862","article-title":"Low-dose retinoic acid enhances in vitro invasiveness of human oral squamous-cell-carcinoma cell lines","volume":"85","author":"Uchida","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"19","key":"10.1016\/j.ygyno.2008.11.015_bib41","first-page":"7065","article-title":"Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells","volume":"61","author":"Rexer","year":"2001","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.ygyno.2008.11.015_bib42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0021-9673(98)00676-1","article-title":"Quantitative determination of endogenous retinoids in mouse embryos by high-performance liquid chromatography with on-line solid-phase extraction, column switching and electrochemical detection","volume":"828","author":"Sakhi","year":"1998","journal-title":"J. Chromatogr. A"},{"issue":"4","key":"10.1016\/j.ygyno.2008.11.015_bib43","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0300-9629(93)90392-H","article-title":"A comparison of serum retinol concentration between human and different species of normo and hypercholesterolemic nonhuman primates fed semi-purified diets with defined amounts of vitamin A","volume":"106","author":"Rogers","year":"1993","journal-title":"Comp. Biochem. Physiol. Comp. Physiol."},{"key":"10.1016\/j.ygyno.2008.11.015_bib44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"12","key":"10.1016\/j.ygyno.2008.11.015_bib45","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/cncr.11848","article-title":"Prophylactic oophorectomy: a morphologic and immunohistochemical study","volume":"98","author":"Schlosshauer","year":"2003","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2008.11.015_bib46","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"issue":"14","key":"10.1016\/j.ygyno.2008.11.015_bib47","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","article-title":"Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy","volume":"18","author":"Lu","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2008.11.015_bib48","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I","article-title":"Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations","volume":"86","author":"Deligdisch","year":"1999","journal-title":"Cancer"},{"issue":"24","key":"10.1016\/j.ygyno.2008.11.015_bib49","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/jnci\/88.24.1810","article-title":"Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies","volume":"88","author":"Salazar","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2008.11.015_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00004347-199904000-00009","article-title":"Histopathologic features of ovaries at increased risk for carcinoma. a case-control analysis","volume":"18","author":"Sherman","year":"1999","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2008.11.015_bib51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004347-199301000-00008","article-title":"Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions","volume":"12","author":"Mittal","year":"1993","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2008.11.015_bib52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/1097-4652(2000)9999:999<000::AID-JCP1043>3.0.CO;2-5","article-title":"Metabolic conversion of retinol to retinoic acid mediates the biological responsiveness of human mammary epithelial cells to retinol","volume":"186","author":"Hayden","year":"2001","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.ygyno.2008.11.015_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1014815112078","article-title":"Alterations in cellular retinol metabolism contribute to differential retinoid responsiveness in normal human mammary epithelial cells versus breast cancer cells","volume":"72","author":"Hayden","year":"2002","journal-title":"Breast Cancer Res. Treat."},{"issue":"55","key":"10.1016\/j.ygyno.2008.11.015_bib54","doi-asserted-by":"crossref","first-page":"7935","DOI":"10.1038\/sj.onc.1204971","article-title":"Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression","volume":"20","author":"Zhang","year":"2001","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.ygyno.2008.11.015_bib55","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/annonc\/mdi265","article-title":"Retinoid receptors in ovarian cancer: expression and prognosis","volume":"16","author":"Kaiser","year":"2005","journal-title":"Ann. Oncol."},{"issue":"47","key":"10.1016\/j.ygyno.2008.11.015_bib56","doi-asserted-by":"crossref","first-page":"45408","DOI":"10.1074\/jbc.M204600200","article-title":"Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line","volume":"277","author":"Holmes","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ygyno.2008.11.015_bib57","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1152\/physrev.2000.80.3.1021","article-title":"Retinoids in embryonal development","volume":"80","author":"Ross","year":"2000","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.ygyno.2008.11.015_bib58","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/carcin\/21.7.1271","article-title":"Retinoids in chemoprevention and differentiation therapy","volume":"21","author":"Hansen","year":"2000","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.ygyno.2008.11.015_bib59","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/excr.1997.3769","article-title":"Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid","volume":"237","author":"Wu","year":"1997","journal-title":"Exp. Cell Res."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808009505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808009505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:26:44Z","timestamp":1758770804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808009505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0090825808009505"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.11.015","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin A metabolism is impaired in human ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}